This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for central nervous system (CNS) disorders. Its structure, featuring a pyrrolidine ring, makes it a valuable building block for designing compounds that interact with neurotransmitter systems. It is often employed in the production of drugs targeting conditions like Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders. Additionally, it serves as a precursor in the synthesis of chiral molecules, leveraging its stereochemistry to achieve high enantiomeric purity in final products. Its hydrochloride form enhances solubility, making it suitable for various chemical reactions and formulations.